| 1 |
Jeong MH, Son T, Tae YK, Park CH, Lee HS, Chung MJ, Park JY, Castro CM, Weissleder R, Jo JH, Bang S, Im H. Plasmon-Enhanced Single Extracellular Vesicle Analysis for Cholangiocarcinoma Diagnosis. Adv Sci (Weinh) 2023;10:e2205148. [PMID: 36698298 DOI: 10.1002/advs.202205148] [Reference Citation Analysis]
|
| 2 |
Gkountakos A, Martelli FM, Silvestris N, Bevere M, De Bellis M, Alaimo L, Sapuppo E, Masetto F, Mombello A, Simbolo M, Bariani E, Milella M, Fassan M, Scarpa A, Luchini C. Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment. Cancers (Basel) 2023;15. [PMID: 36900245 DOI: 10.3390/cancers15051454] [Reference Citation Analysis]
|
| 3 |
Labiano I, Huerta AE, Arrazubi V, Hernandez-Garcia I, Mata E, Gomez D, Arasanz H, Vera R, Alsina M. State of the Art: ctDNA in Upper Gastrointestinal Malignancies. Cancers (Basel) 2023;15. [PMID: 36900172 DOI: 10.3390/cancers15051379] [Reference Citation Analysis]
|
| 4 |
Kanai M. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan. Curr Oncol 2022;29:7272-84. [PMID: 36290850 DOI: 10.3390/curroncol29100573] [Reference Citation Analysis]
|
| 5 |
Tivey A, Church M, Rothwell D, Dive C, Cook N. Circulating tumour DNA - looking beyond the blood. Nat Rev Clin Oncol 2022. [PMID: 35915225 DOI: 10.1038/s41571-022-00660-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
Arrichiello G, Nacca V, Paragliola F, Giunta EF. Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives. Exploration of Targeted Anti-tumor Therapy 2022. [DOI: 10.37349/etat.2022.00087] [Reference Citation Analysis]
|
| 7 |
Shen N, Zhu B, Zhang W, Nian B, Xu X, Yu L, Ruan X, Chen S, Liu Y, Cao X, Shi X, Li Z, Huang X, Wang X, Chen C, Xiong L, Zhang D, Fu X, Zhang Y. Comprehensive Evaluation and Application of a Novel Method to Isolate Cell-Free DNA Derived From Bile of Biliary Tract Cancer Patients. Front Oncol 2022;12:891917. [PMID: 35600407 DOI: 10.3389/fonc.2022.891917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Rizzo A, Ricci AD, Brandi G. Bile cell‑free DNA: a game changer for management of biliary tract cancer? ESMO Open 2022;7:100389. [PMID: 35121524 DOI: 10.1016/j.esmoop.2022.100389] [Reference Citation Analysis]
|
